10x Science is an AI-native platform for next-generation protein characterization. The company develops frontier AI models to automate the analysis of protein therapeutics, addressing a major bottleneck in drug development where characterization currently takes months of manual work. 10x Science is part of Y Combinator's Winter 2026 batch.
10x Science
ActiveThe AI-native platform for next-generation protein characterization
Total raised
$500K
1 round
Stage
Seed
Jan 2026
Team
1-10
since 2026
Pricing
—
Founded
2026
San Francisco, United States
Agent-ready
—
AI-native platform for protein characterization
Frontier AI models built for analyzing protein therapeutics
Automates analysis steps that traditionally take months of manual work
Targets a key bottleneck in drug development
Designed for next-generation protein characterization workflows
Aims to deliver faster, more scalable characterization results
Applies machine learning to complex biologics data
Built to reduce manual effort for scientists
12/100
Early
MCP server
Public API
Webhooks
OAuth 2.0
SDKs
No public agent surfaces detected yet.
Jan 2026 Seed $500K ● Y Combinator
Capital network
$500K raised ·1 backer·10 network links
- Backers1
- Shared portfoliocompanies these backers also fund
- Extended networkfunds that co-invest alongside them
Resolve AI
AI SRE for complex production environments
AI AgentsAI Developer Tools
deepset
Haystack framework and deepset Cloud for enterprise LLM apps
AI AgentsAI Developer Tools
Wordware
Build AI agents by writing in plain English
AI AgentsAI Productivity
Wonderful
Multilingual enterprise AI agents for customer service
AI AgentsAI Productivity
Cursor
The AI code editor built for productive engineers.
AI CodingAI Agents
Oasis Security
Agentic access management to secure AI agents and non-human identities
AI AgentsAI for Cyber Defense
- What does 10x Science do?
- It is an AI-native platform that uses frontier AI models to automate the characterization of protein therapeutics, a process that traditionally requires months of manual work.
- Why is protein characterization a bottleneck?
- Characterizing protein therapeutics is slow and labor-intensive, often taking months, which delays drug development. 10x Science aims to automate and accelerate that step.
- Who would use 10x Science?
- Biotech and pharma teams developing protein-based therapeutics that need faster, more scalable characterization of their candidates.
- How mature is the company?
- 10x Science is an early-stage company and part of Y Combinator's Winter 2026 batch, so it is still building out its platform and customer base.
Discussion
Sign in to join the discussion.
Sign inExplore more around 10x Science
Contextual paths to related AI startups, deals and rankings.